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Abstract
Background: The transcriptional silencing of one X chromosome in eutherians requires transcription of the long
non-coding RNA gene, XIST. Many regulatory elements have been identified downstream of the mouse Xist gene,
including the antisense Tsix gene. However, these elements do not show sequence conservation with humans, and
the human TSIX gene shows critical differences from the mouse. Thus we have undertaken an unbiased
identification of regulatory elements both downstream and upstream of the human XIST gene using DNase I
hypersensitivity mapping.
Results: Downstream of XIST a single DNase I hypersensitive site was identified in a mouse undifferentiated ES cell
line containing an integration of the human XIC region. This site was not observed in somatic cells. Upstream of
XIST, the distance to the flanking JPX gene is expanded in humans relative to mice, and we observe a
hypersensitive site 65 kb upstream of XIST, in addition to hypersensitive sites near the XIST promoter. This -65
region has bi-directional promoter activity and shows sequence conservation in non-rodent eutheria.
Conclusions: The lack of regulatory elements corresponding to human TSIX lends further support to the argument
that TSIX is not a regulator of XIST in humans. The upstream hypersensitive sites we identify show sequence
conservation with other eutheria, but not with mice. Therefore the regulation of XIST seems to be different
between mice and man, and regulatory sequences upstream of XIST may be important regulators of XIST in non-
rodent eutheria instead of Tsix which is critical for Xist regulation in rodents.
Background
X-chromosome inactivation results in transcriptional
silencing of one of the two X chromosomes in female
mammals, thereby ensuring dosage equivalence of most
X-linked genes between males and females. The X inac-
tivation centre (XIC) is a single locus on the X chromo-
some that is required in cis for X-chromosome
inactivation [1]. The XIC contains the X Inactive Speci-
fic Transcript (XIST/Xist) gene that produces a large
(approximately 17 kb) noncoding RNA [2-4] that is
necessary and sufficient to induce X inactivation [5-7].
X inactivation occurs very early in mammalian develop-
ment, making analysis of the initial events challenging,
particularly in humans. Most analyses have therefore
been done in mouse, where ES cells not only provide
the ability to generate targeted mutations, but also
provide an in vitro system modelling X inactivation, as
female ES cells undergo random X inactivation upon
differentiation [8]. Detailed analyses of the genomic
region downstream of the mouse Xist locus have
revealed several cis-acting regulatory elements for Xist
(see Figure 1A), including Tsix [9], DXPas34 and Xite
[10].
The Tsix gene encodes an untranslated RNA antisense
to Xist that is transcribed across the Xist locus, extend-
ing beyond the promoter of the sense strand [9,11]. A
critical role for Tsix in regulating Xist expression was
demonstrated by augmented Tsix expression resulting in
inhibition of Xist accumulation [12] while deletion of
the Tsix promoter resulted in primary non-random
inactivation of the mutant X in females [13]. DXPas34,
a 1.2 kb CG-rich region located 750 bp downstream of
the Tsix major promoter, is critical for Xist and Tsix
regulation, and shows bi-directional promoter activity
[14,15]. Xite, named as the X-inactivation intergenic
transcription element, was identified by DNase I
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reproduction in any medium, provided the original work is properly cited.Figure 1 Mapping DNase I hypersensitive sites downstream of XIST. A schematic of the mouse (A) and human (B) Xist/XIST genes and
surrounding regulatory elements shows exons (black boxes) for Xist/XIST and other genes in the region (arrows indicate the direction of
transcription). Grey dots show the location of conserved blocks between mouse and human [15], and triangles mark DNase I hypersensitive
(DHS) sites (filled triangles - sites in undifferentiated cells; empty triangles - sites in differentiated cells; HS1, HS5 - HS7 [40], HS2 - HS4 [46,47], HS8
- HS15 [55]). DNA from nuclei of ES-10, L1.10.1 and Xa and Xi-containing hybrids exposed to DNaseI was digested with restriction enzymes (ScaI
(10 kb); SapI/BlpI (10.2 kb); NsiI (11.1 kb); XmnI (9.3 kb); NcoI (11.1 kb) and BamHI (6.4 kb)) for Southern analysis. All experiments were carried out
at least twice and a representative Southern blot is shown for each fragment including a lane with no DNase I (parental fragment shown as
black arrow) followed by six lanes of increasing amount of DNase I treatment. One HS site (grey arrow), was detected in the SapI/BlpI fragment
of ES-10 cells, with a size of ~7 kb. No HS site was detected in the XmnI fragment which encompasses the four previously reported transcription
start sites of TSIX [32]. No HS site was detected in either the Xa or Xi hybrid downstream of XIST.
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tional transcription, although the transcripts themselves
are not necessary for Xite to promote Tsix persistence
on the active X [10]. Homologous pairing of a region
downstream of Xist, encompassing Tsix, DXPas34 and
Xite, is necessary for the initiation of X inactivation
[16,17]. This pairing can be recapitulated by sub-
fragments which contain a high density of CTCF sites,
and CTCF as well as transcription is essential for the
establishment of pairing [16].
While the mouse system provides an excellent frame-
work from which we can understand the process of X
inactivation, how human fits into this framework is not
clear. XIST and Xist share sequence homology [3,4] and
are each sufficient to initiate silencing [18,19]; however,
there are substantial differences between the two species
in other aspects of X-chromosome inactivation. Signifi-
cantly, X inactivation is imprinted in mouse extraem-
bryonic tissues [20] but not in humans (reviewed in
[21]) and Tsix is very different from TSIX in patterns of
expression and extent of transcription across the sense
strand [22-24]. Human TSIX has been observed in
embryoid bodies and a human embryonal carcinoma
cell line, but also in chorionic villus cells [22,24]. TSIX
is also expressed in mouse ES-10 cells carrying a multi-
copy integration of a 480 kb XIST-containing human
YAC transgene [25] and in L1.10.1, a clone of a somatic
male cell line transfected with a human XIST-containing
PAC, which contains at least 50 kb of flanking genomic
DNA [26]. While these cells did not show identical
initiation sites for the TSIX transcript, in all cases the
TSIX transcript truncated well before the 5’ end of
XIST. As human ES cells have been variable in their X
inactivation status (e.g. [27]), mouse ES cells with a
human transgene remain one of the best models for
human X inactivation. Multi-copy integrations of the
480-kb transgene containing human XIST display partial
X inactivation center function upon in vitro differentia-
tion of male mouse embryonic stem cells, including acti-
vation in some cells of the endogenous mouse Xist locus
[28,29].
Given the importance of XIST for X inactivation, it is
perhaps surprising that the X inactivation center region
shows little sequence conservation surrounding XIST
between mouse and human [30,31]. In addition to XIST,
the region contains several conserved genes and a num-
ber of non-coding RNAs and pseudogenes. Downstream
of Xist the closest gene is the testes-specific Tsx gene in
mouse, however TSX i sap s e u d o g e n ei nh u m a n[ 3 2 ] .
The closest gene upstream of XIST is the JPX (also
known as ENOX) non-coding RNA gene. Interestingly,
the region between JPX and XIST is ~90 kb in human,
which is approximately 9 times larger than that of
mouse. Thus rearrangements downstream of XIST
where the mouse regulatory elements are found may
have been compensated for by regulatory regions
upstream of the gene. To identify such regulatory ele-
ments in the absence of substantial sequence conserva-
tion we have used DNase I hypersensitive site mapping
as an unbiased approach to identify cis-acting regulatory
elements in humans. Genomic regions hypersensitive to
DNase I digestion (DHS sites) have been shown to har-
bour cis-regulatory elements critical for gene regulation
[33], and both of the mouse Xist regulatory regions
DXPas34 and Xite show DNase I hypersensitivity [12].
Here, we report the identification of three previously
unknown hypersensitive sites surrounding the human
XIST locus.
Results
Identification of DHS sites 3’ to human XIST
The critical timing for XIST regulation is early in devel-
opment and thus for mapping of DHS sites 3’ to human
XIST we used the mouse undifferentiated embryonic
stem cell line ES-10 which contains a human XIST
transgene. We also examined the L1.10.1 cell line which
is a somatic male HT1080 cell line transfected with a
PAC containing the XIST region, and which expresses
XIST as well as TSIX. Additionally, we examined
mouse/human somatic cell hybrids containing either the
human active (Xa) or inactive (Xi) chromosome, which
provide a unique opportunity to compare the chromatin
s t r u c t u r eb e t w e e nt h eX ia n dX ai n d e p e n d e n to fe a c h
other without requiring allele-specific detection. We
generated three probes downstream of XIST that were
able to detect six overlapping restriction fragments
allowing the analysis of a 43 kb region (see Figure 1B).
Only one DHS site, located approximately 12 - 13 kb
downstream of XIST, was identified in the ES-10 cells.
This DHS site does not correspond to the cluster of
four TSIX transcription start sites described in these
cells, which are located approximately 14 kb further
from the 3’ end of XIST [25]. The DHS site is close to
the antisense transcription start in L1.10.1 cells. Inter-
estingly, however, the DHS site was not found in
L1.10.1 (Figure 1B), nor were any others, despite pre-
vious detection of antisense transcript both with RT-
PCR and FISH in this cell line [24]. We confirmed the
ongoing presence of antisense transcript in the L1.10.1
cells used for DHS mapping by RT-PCR (data not
shown). DHS mapping in both Xi and Xa hybrids did
not show the presence of any DHS site downstream of
XIST, including at the region identified to contain a
DHS in ES-10 cells (Figure 1B). It thus appears that,
unlike the situation in mouse where there are both
developmental-specific and constitutive DHS sites
downstream of Xist, in humans there is only a single
developmental-specific DHS site downstream of XIST.
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The lack of putative regulatory elements 3’ to XIST,
where many of the mouse transcriptional regulatory
sites are located, led us to examine the region 5’ to
XIST which is larger in humans than it is in mouse [30].
We generated three probes to examine the region
upstream of human XIST for DHS sites. Almost 80% of
the just over 90 kb region upstream of XIST is com-
prised of repetitive elements, predominantly LINE1
(39.5%) and ALU (27.3%) as identified by repeatmasker
(http://www.repeatmasker.org/[34]). This high repeat
content precluded examination of the entire region and
the restriction fragments assessed by the three probes
interrogate a total of 39 kb in the 90 kb region.
We again performed Southern analysis with DNA iso-
lated after increasing DNase I treatment from cells of
ES-10, an Xa-containing, and an Xi-containing somatic
cell hybrid (Figure 2). The presence of multiple bands
for proximal but not distal probes in ES-10 can be
explained by the individual copies of the XIST transgene
present in the multi-copy integration transgenes not
containing the same amount of DNA sequence flanking
the XIST locus. We observed one or more DHS site(s)
immediately upstream of XIST in ES-10, as well as in
the Xa-containing hybrid where XIST is silenced. These
sites were observed variably in Xi-containing hybrids
where XIST continues to be expressed (Figure 2). While
no other hypersensitive sites were detected upstream of
XIST in ES-10, one DHS site was found approximately
65 kb upstream of the XIST transcription start on both
the active and inactive X chromosomes in somatic
hybrids (Figure 2).
The location of the -65 DHS site was refined by
repeating the DHS mapping with two other restriction
enzyme digests for the Xa-containing hybrid (Figure
3A), thereby refining the location of the site to between
73,053,323 and 73,053,866 (hg18). A dot-plot sequence
comparison of human to cow, and human to mouse
sequences showed that within the region approximately
60 kb upstream of XIST there is a region of
Figure 2 DNase I hypersensitivity mapping upstream of XIST. Below the schematic of the XIST region (see legend in Figure 1) are Southern
blots of DNA from ES-10, an Xa hybrid, and an Xi hybrid. Small rectangular boxes are probes for Southern blotting of overlapping restriction
fragments (from left to right: PstI (13.1 kb); BsmI (10.3 kb); NdeI (7.2 kb); SapI (6.7 kb); SpeI (6.3 kb); ScaI (3.8 kb)). All experiments were carried out
at least twice. One HS site, highlighted by the open arrow, was detected just upstream of the transcriptional start site, within the SpeI fragment,
at somewhat variable positions in the three cell lines. Another HS site was found within the BsmI fragment approximately 65 kb upstream of the
XIST transcription start in both Xa and Xi hybrids (grey arrow). No other DNase I hypersensitive sites were observed.
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human and cow, but not mouse (Figure 3B and 3C).
This region is also conserved in dog (data not shown).
The novel -65 DHS site identified with both the Xa and
Xi in somatic hybrids is located within this conserved
region.
To determine the biological relevance of this con-
served sequence that results in a DHS in somatic cells
we cloned several regions of XIST into the pGL4 series
of plasmids to assay promoter and enhancer activity by
monitoring luciferase reporter activity after transient
transfection into HT1080 somatic cells (Figure 4). We
cloned three ~700 bp regions of the XIST promoter
region (named -3, -2, -1) as well as a 1,087 bp region at
the -65 DHS site in both orientations. There was a nota-
ble orientation bias for regions around the XIST promo-
ter, and in fact -3 could not be cloned in one
orientation. As pGL4.10 lacks a minimal promoter,
assaying luciferase activity monitors promoter activity;
while pGL4.23 contains a minimal promoter and there-
fore monitors enhancer activity. In both assays the -65
region showed significant activity, when cloned in both
orientations. Thus, like many of the mouse regulatory
regions, the -65 DHS seems to have bi-directional pro-
moter and enhancer activity.
Discussion
X-chromosome inactivation in both humans and mice
requires the presence in cis of the X-inactivation center,
and the XIST/Xist gene contained therein. Interestingly,
the XIST gene appears to have evolved in eutherians
from a protein-coding gene, Lnx3 [31], and while critical
r e g i o n ss u c ha st h e5 ’ A repeats required for silencing
are conserved [19,35], other regions of XIST are more
variable amongst the eutheria [36]. Extensive studies in
mouse models have defined a wide variety of regulatory
elements for Xist including Tsix, DXPas34 and Xite.
These elements are all located 3’ to Xist, between Xist
and the adjacent testes-specific Tsx gene. In humans
TSX is a non-expressed pseudogene, and the blocks of
sequence conservation previously reported between
humans and mice 3’ to XIST are ancestral TSX exons
[31,32]. The human TSIX region lacks an equivalent to
the mouse CpG island that was shown to be essential
for function of Tsix [13,32,37]. Other significant differ-
ences between mouse and human Tsix/TSIX include a
lower level of human TSIX transcription and termina-
tion of human TSIX prior to the XIST promoter [24,32],
while antisense transcription across the mouse Xist pro-
moter region is necessary for antisense function [38]. In
addition, Migeon et al. (2002), using RNA FISH for cel-
lular localization of transcripts, showed that human
TSIX transcripts are co-expressed with XIST from the
inactive X throughout human embryonic development,
Figure 3 Localization of the -65 DNase I hypersensitive site
upstream of XIST. A. Using an Xa hybrid to limit background from
cross-hybridization to human material, two additional restriction
digests were performed on different DNA preparations after
increasing DNase I treatments to refine the location of the -65 site.
The BglII fragment is 9.3 kb and the fragment resulting from HS and
restriction digestion is 5 kb (grey arrow, left panel). The ScaI
fragment is 11.8 kb and the fragment resulting from HS and
restriction digestion is 8 kb (grey arrow, right panel). Dot-plot
analyses http://mulan.dcode.org/ showing comparison of sequence
upstream of XIST between cow (38 kb) and human (92 kb) (panel B)
and mouse (10 kb) and human (92 kb) (panel C).
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[22] leading to the argument that Tsix regulation of Xist
may be specific to mouse [39].
Upstream of XIST/Xist the adjacent gene is JPX/
ENOX, which is conserved in humans and mice [30],
although the distance to the JPX CpG island and first
exon is larger in humans (~90 kb) than in mice (less
than 10 kb) [30]. JPX is a non-coding RNA gene includ-
ing different repetitive elements in different species, and
the promoter of the mouse Jpx gene has been shown to
interact with the Xist promoter in undifferentiated ES
cells [40]. No sequence conservation between humans
and mice is found in the region between Jpx and Xist;
however, there is conservation between humans and
cows (and also dogs, data not shown), including an exon
of the Rasl11c pseudogene [31].
The lack of sequence conservation between human
and mouse in the region flanking XIST/Xist,a sw e l la s
the differences in the TSIX/Tsix transcript, led us to
undertake this study to identify potential regulatory ele-
ments for XIST b yu s i n gD H Sm a p p i n gb o t hd o w n -
stream and upstream of XIST. Downstream of XIST in
the region where most regulatory elements are observed
for mouse Xist we find only a single DHS, and this is
only observed in undifferentiated mouse ES cells con-
taining a human XIC transgene. While this site mapped
close to one of the previously described human TSIX
transcription start sites, the presence of the DHS did
not correlate with TSIX transcription, and thus we con-
sider it more likely that this DHS is reflective of a devel-
opmental event not regulating antisense transcription.
As previously reported there is no substantial sequence
conservation between cow, human and mouse down-
stream of XIST [24,30], and dog also fails to show
homologous regions (data not shown). In this region
downstream of XIST the human sequence is enriched
for LTR class repetitive elements, while mouse and dog
are enriched in LINE elements. It has been demon-
strated that in addition to a cis-regulatory role in XIST
regulation, the mouse Tsix and Xite regulatory elements
are also involved in a trans-regulation involving a transi-
tory pairing of homologous X chromosomes proposed
to establish the mutually exclusive choice of the future
active and inactive X chromosomes in females [41]. As
Figure 4 Dual luciferase reporter assays examining promoter and enhancer activities for DNA fragments containing HS site.T h e
pGL4.10 vector, which contains the promoterless synthetic firefly luc2, was used in the promoter assay (left). The pGL4.23 vector, which contains
the synthetic firefly luc2 driven by a minimal promoter, was used in the enhancer assay (right). The histograms show a summary of the ratio of
luciferase activity (adjusted by dividing the firefly luciferase with the control Renilla luciferase) for each insert (from the HS sites shown in lower
panel) relative to the luciferase activity for pGL4.10 or pGL4.23. Each fragment was tested in triplicate and experiments were carried out three
times independently. Error bars represent the standard deviations of three trials. While fragments upstream of the XIST promoter containing HS
sites showed background luciferase activity, fragment -65 displayed five fold and seven fold increases in promoter activity and ten fold and six
fold increases in enhancer activity in the XIST and antisense orientation, respectively.
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capable of inducing expression of the single Xist gene in
these male ES cells [29], it is plausible that the DHS
identified in the transgene 3’ to XIST is involved in such
trans-interactions. There is now genome-wide mapping
of DNase I hypersensitive sites [42] as well as histone
modifications and CTCF binding sites, which often
mark promoters and enhancers [43,44] in a number of
cultured cell lines or human CD4+ cells. The genome-
wide mapping of CTCF sites in somatic cells did not
identify any enrichment in the region of this 3’ DHS.
However, we also did not observe this DHS in somatic
cells. Enhancer sequences have been reported to show
cell-type specific patterns [45], so this region may con-
tain an enhancer specific to undifferentiated cells.
We found evidence for DHS sites near the transcrip-
tional start site of XIST in both somatic and ES-10 cells.
XIST is expressed in the ES-10 cells prior to differentia-
tion, however it is not expressed in the Xa-containing
hybrid cells, thus these sites are observed independent
of XIST expression. We did not refine the localization of
these sites, as they likely correspond to the minimal
XIST promoter and regulatory elements. The minimal
mouse promoter has been shown to have a cluster of
DHS sites [46,47]. In agreement with the previously
defined human minimal promoter [48] we detected
strong promoter activity in our transient luciferase assay
using 1 kb of DNA surrounding the XIST transcription
start site (data not shown). Although a CTCF binding
site has previously been defined at -43 bp of the XIST
promoter [49], genome-wide mapping in CD4
+ Tc e l l s
only identified CTCF binding further upstream [43].
This would correspond to our fragment 3 which showed
limited promoter or enhancer activity in the ‘reverse’
orientation, but was unable to be cloned in the ‘forward’
orientation where it would be aligned with the test pro-
moter in the same orientation it is aligned to XIST in
the human genome. Genome-wide mapping of DHS
sites identified a DHS site approximately three kb
upstream of the promoter, in the vicinity of the CTCF
site, as well as sites further within XIST that our analysis
would not have detected [42]. Thus it appears that there
is a regulatory element for human XIST ~three kb
upstream of the XIST promoter which includes CTCF
binding sequences.
Further 5’ to XIST w ef i n daD H Ss i t ei nar e g i o n
sharing sequence conservation with cow and dog (data
not shown). A DHS site in this region can also be
observed in the genome-wide mapping in CD4
+ T cells,
and furthermore genome-wide H3K4me1 enrichment,
which is characteristic of enhancers, flanks the site [45].
We refined the location of the DHS to between
73,053,323 and 73,053,866, while the DHS site identified
by the global mapping is slightly proximal at
73,053,237- 73,053,138. This might reflect subtle discre-
pancies in mapping, or between cell types. The region
cloned for subsequent enhancer and promoter activity
analysis was 73,054,787 -73,053,643 and would contain
the H3K4me1 marked regions [45] and the majority of
the region to which our DHS site was mapped, but be
just upstream of the DHS site mapped in CD4+ cells
[42].
Overall we find fewer regulatory elements in human
than have been identified in mice. This could be due to
higher repetitive element content in human which made
analyzing the whole region challenging. Furthermore,
the repetitive elements themselves might harbour regu-
latory elements. Indeed, the TSIX transcription starts
mapped by Migeon et al.w e r et oM E R 5 8 B ,A l u Ya n d
L2 class repetitive elements [32], and conservation of
repetitive elements between the mouse Tsix transcrip-
tion start and humans was noted by Cohen et al. [15].
While acquisition of repetitive elements may have led to
an expansion of the XIC region in humans compared to
mice, the conservation upstream of XIST between
humans and other eutheria, including homology to an
exon of the Rasl gene of chicken [31] suggests that this
region was likely lost in rodents.
While many XIST regulatory elements do not appear
to be conserved between humans and mice, many of the
basic events required for X-chromosome inactivation
must be conserved (reviewed in [21]). The 3’ DHS site
might demarcate a developmental-specific regulatory
region that participates in the trans pairing interactions
involved in initiation [17,41]. It has been proposed that
a critical function of TSIX is to partition chromatin
domains in the XIC [50]. Perhaps the 5’ regulatory
regions we have identified are capable of recapitulating
such a function in humans. However we did not observe
a consistent difference between the active and inactive
X chromosomes for these DHS sites, and genome-wide
chromatin mapping in somatic cells does not show evi-
dence for a chromatin domain ending at the -65 DHS.
Ultimately testing whether human X inactivation
involves regulatory processes related to those detailed in
mouse will require the challenging investigation of
human XIST expression during early development. It
has been shown that X chromosome inactivation is
initiated in human preimplantation embryos [51]; how-
ever, human ES cells have shown considerable variability
(e.g. [27]), making mouse ES cells with human XIST
transgenes one of the best current models to study regu-
lation of human XIST.
Conclusions
DNase I hypersensitivity mapping around the human
XIST gene has identified fewer candidate regulatory
regions than are observed flanking mouse Xist.I n
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fic DHS site was observed in undifferentiated mouse ES
cells with an integration of the human XIST domain. 5’
to XIST aD H Ss i t ew a si d e n t i f i e di nar e g i o no f
sequence conservation amongst non-rodent eutheria.
This region showed bi-directional promoter and enhan-
cer activity. The lack of conservation of regulatory ele-
ments for XIST lends support to previous conjectures
that human TSIX is no longer a functional regulator of
XIST.
Methods
Tissue Culture & Cell Lines
ES-10 cells, a derivative of J1 male mouse embryonic
stem cells with a 480-kb human XIC transgene, were
generously provided by Dr. B. Migeon and maintained
as described [22]. The L1.10.1 transgenic derivative of
human male fibrosarcoma cell line HT-1080 was grown
as described [19]. Mouse-human somatic cell hybrids
t11-4Aaz5 (containing a human Xi as well as six human
autosomes in addition to mouse chromosomes) and t60-
12 (containing a human Xa) were maintained as
described [52].
DNase I Hypersensitivity Mapping
The preparation of nuclei and the DNase I digest were
as described [53]. Briefly, cells were harvested and
washed twice in ice-cold PBS, then resuspended at 1 ×
10
7 cells/ml in 10 ml ice-cold sucrose-triton, swelled on
ice for 15 minutes, and then homogenized 10 times in a
Dounce homogenizer with a B pestle (7 ml, Wheaton).
Homogenized cells were transferred to a 15-ml falcon
tube and spun at 1,200 rpm for 15 min at 4°C to
recover nuclei which were then resuspended in 1.5 ml
of ice cold buffer (50 mM Tris-Cl pH7.9, 100 mM
NaCl, 3 mM MgCl2, 1 mM dithiothreitol, 0.2 mM phe-
nymethylsulfonyl fluoride) and aliquoted into seven 1.5
ml eppendorf tubes (200 μl each). Nuclei were digested
with an increasing amount of DNase I (10 U/μl, RNase
free, Roche) (i.e. 1/128, 1/64, 1/32, 1/16, 1/8, 1/4 U/μl)
at 37°C for 20 minutes. The digestions were stopped
and DNA extracted by adding 1 ml DNazol (Invitrogen)
following the manufacturer’s protocol. DNase I treated
DNA was digested with restriction enzymes according
to the manufacturer’s recommendations and analyzed by
Southern blotting with random-primed P
32-labelled
probes generated by PCR with primers listed in Table 1
[53]. All analyses were repeated at least twice. As the
cell lines contain variablep r o p o r t i o n so ft h eh u m a n
genome they showed differences in cross-hybridization.
In order to be identified as a DHS site a band could not
be visible in the undigested lane and needed to be
replicated.
Sequence Comparisons, Plasmid Construction and
Luciferase Assay
For the dot-plot analyses, we used Mulan (http://mulan.
dcode.org/[54]). Five DNA fragments of interest were
generated by PCR amplification of human genomic
DNA from GM01416 for 35 cycles using primers listed
in Table 2. PCR fragments were first cloned into
pGEM®-T Easy vector (Promega) via TA cloning prior
Table 1 Primers for probe generation
Symbol Size Name Sequence (5’ to 3’)
36 921 bp IP368F CTTGCTCACCAATTGACTCGTAAG
IP359R GAGGACGTGTCAAGAAGACACTAGG
45 874 bp IP453F CATGGGAAAGCAGCAGACTTCT
IP444R GGGCCTGAATGTGAGCATAGAT
101 1190 bp IP1011F GAATAGCTCAACTGCCAGTGTTACT
IP1000R GGTCCTCAATGTCCTTTACAAAGC
86 1041 bp U862F TGGAGTCCAGTCGTTGTGCT
U873R ATAATCTTGCTACTGAAGGGGCT
105 1209 bp U1056F TGCTTGAAGGGTTTACTGCTGTC
U1068R CTATACAATGCTCCTGTGATTCTAGTGC
117 1140 bp U1179F CTTCTGCACTCTGCTAAAGTTCTGAC
U1190R TCTGTGACTTGGCAAGCCTTC
Table 2 Primers for cloning
Fragment Content Name Sequence (5’ to 3’)
XIST promoter, positive control 0 F TCGAGCTCCTTGCTCACCAATTGACTCGTAAG
0 R CGGGTACCGAGGACGTGTCAAGAAGACACTAGG
1 kb upstream of XIST promoter -1 kb F TCGAGCTCCATTTCCACACTTGTAGAAACTTCTAGTAG
-1 kb R CGGGTACCCTTACGAGTCAATTGGTGAGCAAG
2 kb upstream of XIST promoter -2 kb F TCGAGCTCGAGCCAAGCAGTAGTGAAGGTGA
-2 kb R CGGGTACCGGTTGTCCTGGGTTTCTGTGA
3 kb upstream of XIST promoter -3 kb F TCGAGCTCCCCCGTGTTCTCTTTTGATAAACTAG
-3 kb R CGGGTACCTCACCTTCACTACTGCTTGGCTC
65 kb upstream of XIST, covers HS 101 -65 kb F TCGAGCTCGTGGAGTACCCTTTCTATCACAACT
-65 kb R CGGGTACCTGGCTTGACTTCTAGGGTAAAGA
* underlined is genomic sequence from NCBI; not underlined is adaptor (i.e. SacI& KpnI sites)
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(Promega) upstream of the firefly luciferase gene. The
identities of pGL4 clones were confirmed by restriction
enzyme digestion and partial sequence analysis. Transi-
ent transfection was performed in 24-well plates with
80% confluent HT1080 cells. 0.8 μg of firefly luciferase
plasmid (pGL4, Promega) and 80 ng of the Renilla luci-
ferase plasmid (Promega) were co-transfected into cells
using 2 μl Lipofectamine™ 2000 (Invitrogen). For each
transfection assay, the pGL4.13 vector, which contains a
promoter/enhancer element, was used as positive con-
trol and the pGL4.10 vector, which contains neither
promoter nor enhancer, was used as negative control.
Transfection of the pGL4.23 vector with a basal promo-
ter also served as a control. After 24 h, cell lysates were
prepared from each transfected culture and were ana-
lyzed in a 96-well plate luminometer (Perkin Elmer
Wallace) according to manufacturer’sp r o t o c o li nt h e
Dual Luciferase Kit (Promega). Each fragment was
tested in triplicate, and each experiment was repeated at
least three times. To control for transfection efficiency,
the ratio of firefly luciferase signal to Renilla luciferase
signal was calculated for each transfected sample.
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